Recently, accumulating evidence has shown that the serum level of visfatin could be linked to the tumorigenicity of cancers, including CRC, gastric cancer, breast cancer, and brain cancer [12,13,14,15]. This evidence concerns the gene NAMPT and colorectal carcinoma.